Note about experimental yellow fever

Yellow fever in the Americas: the growing concern about new

Yellow fever (YF) is a haemorrhagic viral disease with a high case fatality rate. It is considered a reemerging infectious disease of remarkable importance. During the last outbreaks in Angola (2015-2016) and Brazil (2016-2017), many cases of YF emerged despite high YF vaccination coverage, increasing the risk of major epidemics in the Americas. Several factors, including the vast border and mi...

What a rheumatologist needs to know about yellow fever vaccine.

Patients with rheumatic diseases are more susceptible to infection, due to the underlying disease itself or to its treatment. The rheumatologist should prevent infections in those patients, vaccination being one preventive measure to be adopted. Yellow fever is one of such infectious diseases that can be avoided.The yellow fever vaccine is safe and effective for the general population, but, bei...

Yellow fever.

1MD, Infectious Disease Specialist, Hospital Israelita Albert Einstein, Sociedade Brasileira de Infectologia. MSc in Medicine – Infectious and Parasitic Diseases, Faculdade de Medicina da Universidade de São Paulo (FMUSP). PhD in Medicine – Infectious and Parasitic Diseases, FMUSP. Fellow American College of Physicians, São Paulo, SP, Brazil 2MD, Infectious Disease Specialist, Hospital Israelit...

Yellow fever

Yellow fever.

With the infestation by Aedes aegypti, urban yellow fever might already exist. This did not occur because of either the lacking of a sufficient contact between the diseased individual and the A. aegypti or perhaps because this, after sixty years without transmitting the virus, needs an adaptation phase to infecting again.